Spark Therapeutics (ONCE) Misses Q3 EPS by 28c

Spark Therapeutics (NASDAQ: ONCE) reported Q3 EPS of ($1.26), $0.28 worse than the analyst estimate of ($0.98).

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• L3Harris CEO steps down amid conduct review, shares drop